20 June 2017 - President Donald Trump has gone from promising to bring down drug prices to looking like he's been captured by Big Pharma in just a few short months.

The president started out the year ripping into drugmakers and threatening to make firms bid for government business. Now? Rather than pushing for pricing legislation, his administration is reportedly settling for an executive order -- which, according to a Kaiser Health News report, may end up looking more like a pharma wish list than a menu of onerous demands.

The regulations the industry fears most include those that would give the government more negotiating power and limit drug monopolies. Those increasingly seem to be off the table. Even a strong executive order has limitations, and Trump's apparently will not be strong.

Read Bloomberg article